The known association between leptin, obesity and insulin action suggests that leptin may have a role in polycystic ovarian syndrome (PCOS) but this has only been addressed peripherally. METHODS: We assessed the influence of leptin on LH and investigated the relationship between leptin and body mass index (BMI), waist:hip ratio (WHR), androgen concentrations, fasting insulin and insulin:glucose ratio (IGR) in 27 women with PCOS and in 20 age-and weight-matched women with regular, ovulatory menstrual cycles and idiopathic hirsutism (IH). RESULTS: Leptin concentrations were significantly higher in obese PCOS women than in normal weight women with either PCOS or IH (P ⍧ 0.0028), but did not differ between obese women with PCOS and IH. WHR, insulin concentrations and IGR were significantly higher in obese PCOS patients in comparison with the three other groups. In IH patients, the association between leptin concentrations and WHR was lost after adjustment for BMI. In PCOS patients, a significant correlation was observed between leptin and fasting insulin concentrations, IGR, WHR and LH. After adjustment for BMI, only the correlation with LH remained significant. A stepwise regression model was set up with LH as the dependent variable to test the hypothesis that the concentrations of leptin might be modulating the concentrations of LH in PCOS patients. The relationship of LH concentrations with IGR was found to be BMI dependent. In contrast, leptin concentrations contributed negatively and significantly to LH concentrations, independently of either BMI or IGR. CONCLUSIONS: We speculate that the known attenuation in basal or stimulated response of LH in obese PCOS patients might be related to leptin resistance, which could influence LH hypersecretion. In IH ovulatory patients, normal LH concentrations suggest the presence of preserved regulatory mechanisms of GnRH pulsatility. Further studies are needed to specifically investigate the proposed correlation between leptin and GnRH modulation in PCOS.
Introduction
IRS-1 with phosphatidyl-inositol 3-kinase. Therefore, leptin may antagonize some actions of insulin, and thus may have a Leptin, a protein containing 167 amino acids, transcribed from role in obesity-induced insulin-resistance (Cohen et al., 1996) . the obesity (ob) gene, is associated with the regulation of body Moreover, leptin receptors have been reported in the pancreas, fat stores. In rodents, leptin contributes to the regulation of suggesting that leptin may also regulate insulin release as part energy balance (Halaas et al., 1995) and reduces the percentage of an adipo-insular feedback (Wang et al., 1998) . of body fat. In humans, however, leptin resistance is involved Polycystic ovarian syndrome (PCOS) is a heterogeneous in the development of obesity, and is closely related to the clinical condition, characterized by hirsutism, irregular metabolism of insulin and glucose (Auwerx and Staels, 1998) . menstrual cycles, infertility, and endocrine abnormalities such In vitro, leptin seems to attenuate the phosphorylation of as hyperandrogenism and inappropriate LH secretion. Moreinsulin receptor-1 (IRS-1), while increasing the association of over, a considerable percentage of PCOS women present insulin resistance and compensatory hyperinsulinaemia (Dunaif et al., 1989; Holte et al., 1994a; Ehrmann et al., 1995) . These progesterone (Ͼ15.1 nmol/l) and/or its marked increase after normal women within similar age groups. Also, insulin resistadrenocorticotrophic hormone stimulation (Ͼ30 nmol/l) (Spritzer ance seems to be more frequent and/or to cause a higher et al., 1990; Aziz et al., 1994) . Patients with hyperprolactinaemia metabolic impact on obese PCOS women than in non-obese (serum prolactin concentrations Ͼ20 µg/l on two different occasions) PCOS women. At least 20% of the obese PCOS patients were also excluded.
present glucose intolerance or diabetes, versus~5% of the Forty-seven patients, aged 13-39 years, were selected for the study.
healthy age-and weight-matched population (Dunaif et al., None had received any drugs known to interfere with hormonal 1987; Spritzer et al., 1998; Ehrmann et al., 1999) .
concentrations for at least 3 months before the study. Laughlin et al., 1997; Mantzoros et al., 1997;  enlarged polycystic ovaries (Adams et al., 1986; Herter et al., 1996) Rouru et al. Carmina et al., 1999; Mantzoros et al., and absence of ovarian or adrenal neoplasm or Cushing's syndrome.
2000).
Idiopathic hirsutism was diagnosed, as previously described
There is some evidence that, at the level of the central (Spritzer et al., 2000) , heightened LH responses to GnRH are evident in non-obese PCOS patients, the presence of obesity in PCOS women attenuates these neuroendocrine abnormalities (Dale et al., Study protocol 1992; Grulet et al., 1993; Holte et al., 1994b; Anthropometric measurements included body weight, height, waist:
1996; Arroyo et al., 1997; Taylor et al., 1997) . It is possible hip ratio (WHR) (waist circumference was recorded at the narrowest that in these women, hyperleptinaemia could interfere with point or at the umbilicus, and hip circumference at the level of the the mechanism of LH hypersecretion.
greater trochanter), and BMI (current measured weight in kg divided Therefore, the objective of the present study was to assess by height in m 2 ).
the influence of leptin on LH, and to investigate the potential All studies were performed after a 3 day 300 g carbohydrate diet. The hormonal and metabolic assessment was made between days 2 association of leptin with body mass index (BMI), waist:hip and 10 of the menstrual cycle or on any day when the patients were ratio (WHR), androgen concentrations, fasting insulin and amenorrhoeic. After an overnight fast, blood samples were drawn insulin:glucose ratio in women with PCOS and in age-and from an antecubital vein for determination of plasma glucose and weight-matched women with regular, ovulatory menstrual insulin. Blood samples were also drawn for leptin, LH, FSH, sex cycles and idiopathic hirsutism (IH).
hormone binding globulin (SHBG), total testosterone and androstenedione determinations. All samples were obtained between 08:00 and 10:00.
Material and methods
The free testosterone index was estimated as testosterone Patients (nmol/l)/SHBG (nmol/l)ϫ100. Fasting insulin:glucose ratio (IGR, µIU/mg) was calculated by dividing fasting serum insulin by The study population included women treated for hirsutism, seen fasting serum glucose, as previously reported (Spritzer et al. , consecutively during a 2 year period at the Gynecological Endo-1998). The thresh-hold value to define hyperinsulinaemia was crinology Unit at Hospital de Clínicas de Porto Alegre, Brazil. Latearbitrarily established at 23 µIU/mg, taking into consideration the onset (non-classic) congenital adrenal hyperplasia patients were excluded on the basis of a high plasma concentration of 17-hydroxyupper normal limit for insulin (25 µIU/ml) and for glucose (110 7.2 (6.6-9.9)* 2.6 (2.4-4.5) 3.5 (2.0-7.6) LH:FSH ratio c,d
2.2 (1.9-2.9)* 0.7 (0.5-1.1) 0.5 (0.3-2.0)
a Reference values refer to women with regular menstrual and ovulatory cycles and without hirsutism, from the same geographical region and with socio-economic characteristics similar to the study group. mg/dl), and confirmed by receiver operating characteristic (ROC) was used to normalize the distribution of non-Gaussian variables and mean values were back-transformed for presentation. curve analysis.
All analyses were performed using the Statistical Packages for the Social Sciences (SPSS, Chicago, IL, USA). Data were considered to Assays be significant at P Ͻ 0.05. Glucose was measured by the glucose oxidase technique using Mega Merck Kits (Darmstadt, Germany). Serum LH and FSH were measured
Results
by specific immunofluorimetric assay (Wallac, Turku, Finland) with intra-and interassay coefficients of variation (CV) of 6.7 and 11% Table II shows leptin measurements and anthropometric and respectively for LH, and 6.6 and 10.2% for FSH. The sensitivity of metabolic data for patients with PCOS and IH. For this the assays was 0.12 IU/l for LH and 0.05 IU/l for FSH. Serum analysis, patients were stratified into four groups according androstenedione (A) concentrations were measured using the radioto BMI: normal weight PCOS patients; normal weight IH; immunoassay method (Diagnostic Products Corp., Los Angeles, CA, overweight (BMI Ͼ25 kg/m 2 ) PCOS patients; and overweight USA) with an assay sensitivity of 0.06 ng/ml, and intra-and inter-IH patients. Leptin concentrations were significantly higher in assay CV of 4.2 and 7.8% respectively. Total serum testosterone obese PCOS women than in normal-weight women with either concentrations were measured with the radioimmunoassay method PCOS or IH (P ϭ 0.0028), but did not differ between (Diagnostic Products Corp.) with an assay sensitivity of 0.04 ng/ml, obese women with PCOS and IH. Waist:hip ratios, insulin and intra-and inter-assay CV of 8.5 and 10.3% respectively. SHBG was measured by chemiluminescent enzyme immunoassay (DPC, Los concentrations and IGR were significantly higher in obese Angeles, CA, USA) with an assay sensitivity of 0.2 nmol/l, and intra-PCOS patients in comparison with all the other groups. As and inter-assay CV of 6.1 and 8.0% respectively. A double antibody shown in Figure 1 , there was a strong correlation between radioimmunoassay (CIS Bio International, Bedford, MA, USA), serum leptin concentrations and BMI and WHR in both PCOS measured serum insulin concentrations with an assay sensitivity of and IH women.
2.0 µIU/ml, and intra-and inter-assay CV of 7.5 and 9%, respectively. Table III shows the correlation between leptin and fasting Serum leptin concentration was measured with specific leptin immunoinsulin concentrations, fasting IGR, LH and androgen concenradiometric assay kit (Diagnosis Systems Laboratories, Inc., Webster, trations in PCOS and IH patients. In IH patients, leptin TX, USA) with an assay sensitivity of 0.10 ng/ml, and intra-and concentrations were correlated only to WHR. However, the inter-assay CV of 5.7 and 6.3%, respectively. significance was lost after adjustment for BMI. In PCOS patients, a significant correlation was observed between leptin (Table I ). This analysis also aimed at eliminating the influence was also calculated for patients with PCOS in order to explore the of hyperinsulinaemia as a possible confounding factor in PCOS relationship between LH concentration as a dependent variable and leptin, IGR and BMI as independent variables. Log 10 transformation patients, and therefore BMI, IGR and leptin concentrations were included as independent variables. These variables were Discussion significantly correlated with LH (data not shown).
Women with PCOS are characterized by hyperandrogenaemia, As shown in Table IV , the relationship of LH concentrations increased LH concentrations, and high incidence of hyperwith IGR in PCOS patients was found to be BMI dependent.
insulinaemia/insulin resistance and obesity. Thus, PCOS In contrast, leptin concentrations contributed negatively and patients may serve as a reliable model to assess the relationship significantly to LH concentrations, independently of either of hyperinsulinaemia and androgen excess with leptin concentrations beyond the association of leptin with obesity per se. BMI or IGR. 1997; Rouru et al., 1997) . Regarding the association of leptin agreement with other studies . In addition, the correlation between BMI and WHR with serum and previously reported (Considine et al., 1996; Chapman et al., 1997; Gennarelli et al., 1998) between body fat stores and BMI. Together, these findings provide evidence that circulating leptin in PCOS is related to In the present study, PCOS women were assessed and compared the overall and central adiposity that is frequently associated with a group of IH women. We believe that these ovulatory with this syndrome, and not directly related to PCOS itself. IH women are an especially apt control group, since their age, Despite the increasing knowledge regarding leptin physio-BMI and degree of hirsutism are similar to those of PCOS logy (Ahima et al., 1996) , the relationship between the LH women; however, they do not present the clinical and hormonal axis and leptin has only recently become the focus of attention. alterations that are typical of PCOS.
Laughlin et al. observed a BMI-dependent inverse correlation Recent studies have shed some light on the possible effects between 24 h mean LH concentrations and 24 h mean LH of insulin and/or insulin resistance on leptin, and insulin has pulse amplitude and leptin concentrations in PCOS patients, been shown to modulate leptin gene expression (Saladin et al., but not in normal cycling women (Laughlin et al., ). 1995 Friedman and Halaas, 1998) . In addition, a number of Moreover, another study (Sir-Petermann et al., 1999) demonstudies have examined the relationship between leptin and strated a weaker synchronicity, as well as a phase shift between insulin resistance or insulin concentration independently of LH and leptin pulses in PCOS patients in comparison with obesity, although with contradictory results. normal cycling women. In this study, both insulin and IGR were used as markers
In the present paper, we observed a negative correlation of insulin sensitivity. Previous reports have shown that in nonbetween leptin and LH concentrations in PCOS patients, but diabetic subjects, fasting insulin is closely correlated with not in ovulatory women with IH. This correlation remained more direct measures of insulin resistance (Laakso, 1993) . significant even after adjustment for BMI. Furthermore, a Moreover, insulin:glucose ratio or glucose:insulin ratio have stepwise regression model showed that the negative correlation also been shown to be useful measures of insulin resistance between leptin and LH concentrations is independent of either in women with PCOS (Parra et al., 1994; Legro et al., 1998;  BMI or IGR. The independent negative association of leptin Spritzer et al., 1998) .
and LH concentrations reported here was only evident for We observed a correlation between serum leptin concentrapatients with PCOS. tions and fasting serum insulin and IGR in PCOS. However, In general, the pattern of pituitary hormone secretion may such a correlation was accounted for by the association of be viewed as a consequence of the activity of an oscillator these three parameters with BMI, as previously reported modulated by internal or external factors; such an explanation could account for the modulatory effect of leptin on GnRH-(Chapman et al., 1997; Laughlin et al., 1997; Mantzoros et al., 
